PULMATRIX, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
PULMATRIX, INC. (PULM) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $139.00 thousand for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-09-17
- PULMATRIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $276.00K, a 20.52% increase from fiscal 2022.
- PULMATRIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $229.00K, a 76.15% increase from fiscal 2021.
- PULMATRIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $130.00K, a 282.35% increase from fiscal 2020.
- PULMATRIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2020 was $34.00K, a 60.92% decline from fiscal 2019.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month as first filed |
|---|---|---|
| 2024-12-31 | $139.00K S-4/A · filed 2026-09-17 | |
| 2023-12-31 | $276.00K 10-K · filed 2025-03-21 | |
| 2022-12-31 | $229.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $130.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $34.00K 10-K · filed 2022-03-29 | |
| 2019-12-31 | $87.00K 10-K · filed 2021-03-23 | |
| 2018-12-31 | $115.00K 10-K · filed 2020-03-26 | |
| 2017-12-31 | $59.00K 10-K · filed 2019-02-19 | |
| 2016-12-31 | $86.00K 10-K · filed 2018-03-13 | |
| 2015-12-31 | $60.00K 10-K · filed 2017-03-10 | $66.00K 10-K · filed 2016-03-10 |
| 2014-12-31 | $60.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |